In order to further evaluate the effect of ACSL4 expression on the mTOR pathway observed with the MCF-7 Tet-Off/ACSL4 cells, we next produced an ACSL4-overexpressing system using a different non-aggressive breast cancer cell line, i.e. T47D cells. This evidence concerns the gene ACSL4 and breast cancer.